A single amino acid residue regulates PTEN-binding and stability of the spinal muscular atrophy protein SMN

A single amino acid residue regulates PTEN-binding and stability of the spinal muscular atrophy protein SMN

Spinal Muscular Atrophy (SMA) is a neuromuscular disease caused by decreased levels of the survival of motoneuron (SMN) protein. Post-translational mechanisms for regulation of its stability are still elusive. Thus, we aimed to identify regulatory phosphorylation sites that modulate function and sta...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Rademacher, S, Detering, NT, Schüning, T, Lindner, R, Santonicola, P, Wefel, I-M, Dehus, J, Walter, LM, Brinkmann, H, Niewienda, A, Janek, K, Varela, MA, Bowerman, M, Di Schiavi, E, Claus, P
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	MDPI 2020

समान संसाधन

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
द्वारा: Bowerman, M, और अन्य
प्रकाशित: (2017)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
द्वारा: Bowerman, M, और अन्य
प्रकाशित: (2017)

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
द्वारा: Winkelsas, AM, और अन्य
प्रकाशित: (2021)

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
द्वारा: Niba, Emma Tabe Eko, और अन्य
प्रकाशित: (2022)

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
द्वारा: Niba, Emma Tabe Eko, और अन्य
प्रकाशित: (2022)

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
द्वारा: Winkelsas, AM
प्रकाशित: (2020)

Hepatocyte-intrinsic SMN deficiency drives metabolic dysfunction and liver steatosis in spinal muscular atrophy
द्वारा: Leow, Damien Meng-Kiat, और अन्य
प्रकाशित: (2024)

SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy.
द्वारा: Wishart, T, और अन्य
प्रकाशित: (2010)

Spinal muscular atrophy.
द्वारा: Talbot, K, और अन्य
प्रकाशित: (2001)

Analysis of the survival of motor neuron (SMN1) gene mutations in Spinal Muscular Atrophy through models
द्वारा: Owen, N, और अन्य
प्रकाशित: (2002)

High Concentration or Combined Treatment of Antisense Oligonucleotides for Spinal Muscular Atrophy Perturbed SMN2 Splicing in Patient Fibroblasts
द्वारा: Wijaya, Yogik Onky Silvana, और अन्य
प्रकाशित: (2022)

Deletion of smn-1, the Caenorhabditis elegans ortholog of the spinal muscular atrophy gene, results in locomotor dysfunction and reduced lifespan.
द्वारा: Briese, M, और अन्य
प्रकाशित: (2009)

Modeling spinal muscular atrophy in Drosophila.
द्वारा: Chang, H, और अन्य
प्रकाशित: (2008)

Chapter 16 Spinal Muscular Atrophy
द्वारा: Talbot, K, और अन्य
प्रकाशित: (2003)

Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscape
द्वारा: Wood, M, और अन्य
प्रकाशित: (2017)

Development Of EZ DNA Diagnostic Kit For The Detection Of Homozygous Deletion Of SMN1 Gene In Spinal Muscular Atrophy (SMA) Patients
द्वारा: Marzuki, Marini
प्रकाशित: (2012)

The spinal muscular atrophy protein SMN affects Drosophila germline nuclear organization through the U body-P body pathway.
द्वारा: Lee, L, और अन्य
प्रकाशित: (2009)

Splice-switching therapy for spinal muscular atrophy.
द्वारा: Meijboom, K, और अन्य
प्रकाशित: (2017)

A novel point mutation in the Caenorhabditis elegans smn-1 gene provides a useful model for investigating Spinal Muscular Atrophy
द्वारा: Sleigh, J, और अन्य
प्रकाशित: (2010)

Light modulation ameliorates expression of circadian genes and disease progression in spinal muscular atrophy mice
द्वारा: Walter, L, और अन्य
प्रकाशित: (2018)

MOLECULAR ANALYSIS OF CHILDHOOD-ONSET SPINAL MUSCULAR-ATROPHY
द्वारा: Theodosiou, A, और अन्य
प्रकाशित: (1995)

Spinal muscular atrophy at the crossroads of basic science and therapy
द्वारा: Sleigh, J, और अन्य
प्रकाशित: (2013)

Spinal muscular atrophy at the crossroads of basic science and therapy.
द्वारा: Sleigh, J, और अन्य
प्रकाशित: (2013)

Spinal muscular atrophy: disease mechanisms and therapeutic approaches
द्वारा: Meijboom, K
प्रकाशित: (2018)

Infantile spinal muscular atrophy: Therapeutic (R)evolution
द्वारा: Daron, A, और अन्य
प्रकाशित: (2019)

Reversible molecular pathology of skeletal muscle in spinal muscular atrophy.
द्वारा: Mutsaers, C, और अन्य
प्रकाशित: (2011)

The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy.
द्वारा: Sleigh, J, और अन्य
प्रकाशित: (2011)

Modelling of spinal muscular atrophy in D-melanogaster and C-elegans
द्वारा: Davies, K
प्रकाशित: (2004)

Chapter 7 Spinal muscular atrophies and hereditary motor neuropathies.
द्वारा: Talbot, K, और अन्य
प्रकाशित: (2007)

The changing natural history of spinal muscular atrophy type 1.
द्वारा: Oskoui, M, और अन्य
प्रकाशित: (2007)

Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
द्वारा: Hammond, S, और अन्य
प्रकाशित: (2016)

Combining multiomics and drug perturbation profiles to identify muscle-specific treatments for spinal muscular atrophy
द्वारा: Meijboom, KE, और अन्य
प्रकाशित: (2021)

Muscle overexpression of Klf15 via an AAV8-Spc5-12 construct does not provide benefits in spinal muscular atrophy mice
द्वारा: Ahlskog, N, और अन्य
प्रकाशित: (2020)

Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy
द्वारा: Lombardi, V, और अन्य
प्रकाशित: (2019)

New treatments in spinal muscular atrophy: an overview of currently available data
द्वारा: Ramdas, S, और अन्य
प्रकाशित: (2020)

Sitting in patients with spinal muscular atrophy type 1 treated with nusinersen
द्वारा: Aragon-Gawinska, K, और अन्य
प्रकाशित: (2019)

Nusinersen versus sham control in later-onset spinal muscular atrophy
द्वारा: Mercuri, E, और अन्य
प्रकाशित: (2018)

Nusinersen treatment of spinal muscular atrophy: current knowledge and existing gaps
द्वारा: Gidaro, T, और अन्य
प्रकाशित: (2018)

Invertebrate models of spinal muscular atrophy: Insights into mechanisms and potential therapeutics
द्वारा: Grice, S, और अन्य
प्रकाशित: (2011)

From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?
द्वारा: Pennuto, M, और अन्य
प्रकाशित: (2017)